FEATURES / Cross Border
US politics and Merck’s bad public image are keeping a breakthrough vaccine from saving hundreds of thousands of lives around the world— and endangering the cures of the future
Matthew Herper
The search giant has yet to buy a company in 2012. It’s not for lack of appetite, but rather a drastic change of taste
Connie Guglielmo
-
Dallas chemical company Celanese found a way of making ethanol from natural gas that could revolutionise how we fuel America. Too bad there’s a law against it
-
Shipping titan John Fredriksen’s $11 billion fortune has soared while the tanker industry has been tanking. His secret offers a lesson for every industry
-
How one guy who barely spoke English landed in the Bay Area, sold Persian rugs to venture capitalists—and became one of the most successful angels in tech
-
Cracking computers to steal credit cards is passé. Hackers now sell their best tricks to government spies at six-figure prices
-
In a country where “entrepreneur” is a dirty word and the establishment despises him, telecom and web pioneer Xavier Niel has built a $4.5 billion fortune—and become a cult hero
-
Li Ka-shing is betting 16-year-old Nick D’Aloisio can build a better Google
-
Joe Sullivan hunts down the bad guys drawn to the world’s largest social network. How far will he go to keep the site safe—and still protect your privacy?
-
Ocean power almost wiped out. Now it’s making a comeback
-
Manoj Bhargava, the mystery man behind 5-Hour Energy, has taken one of the stranger paths to billions in the annals of the American Dream
-
Give Steve Scott 18 zeroes and a lot of electricity and he can change the world
|
INSTA-SUBSCRIBE to Forbes India Magazine
|
